BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bayan MF, Bayan RF. Recent advances in mesalamine colonic delivery systems. Futur J Pharm Sci 2020;6. [DOI: 10.1186/s43094-020-00057-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ray P, Chatterjee S, Saha P. Screening of polysaccharides from fruit pulp of Ziziphus mauritiana L. and Artocarpus heterophyllus L. as natural mucoadhesives. Futur J Pharm Sci 2021;7. [DOI: 10.1186/s43094-020-00164-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sriram A, Tangirala S, Atmakuri S, Hoque S, Modani S, Srivastava S, Mahajan S, Maji I, Kumar R, Khatri D, Madan J, Singh PK. Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 2021;22:264. [PMID: 34734325 DOI: 10.1208/s12249-021-02133-4] [Reference Citation Analysis]
3 Amiry F, Sazegar MR, Mahmoudi A. Smart polymeric nanocomposite based on protonated aluminosilicate, curcumin, and chitosan for mesalamine drug delivery as an anti-inflammatory nanocarrier. Microporous and Mesoporous Materials 2022;330:111533. [DOI: 10.1016/j.micromeso.2021.111533] [Reference Citation Analysis]
4 Singh A, Mandal UK, Narang RK. Development and In Vivo Evaluation of Pectin Based Enteric Coated Microparticles Loaded with Mesalamine and Saccharomyces boulardii for Management of Ulcerative Colitis. Assay Drug Dev Technol 2021. [PMID: 34780287 DOI: 10.1089/adt.2021.052] [Reference Citation Analysis]
5 Zhang Y, Wo SK, Leng W, Gao F, Yan X, Zuo Z. Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets. J Control Release 2022:S0168-3659(22)00220-6. [PMID: 35461968 DOI: 10.1016/j.jconrel.2022.04.024] [Reference Citation Analysis]